Published in Bioengineering (Basel) on August 18, 2017
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res (2008) 8.49
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Heart regeneration. Nature (2011) 5.91
Stem-cell therapy for cardiac disease. Nature (2008) 5.75
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol (2003) 4.91
3D bioprinting of tissues and organs. Nat Biotechnol (2014) 4.66
Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation (2012) 4.56
Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med (2006) 4.53
Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50
Tissue engineering: creation of long-lasting blood vessels. Nature (2004) 4.50
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater (2012) 4.10
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature (2014) 4.00
Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials (2010) 3.72
Cell therapy for cardiac repair--lessons from clinical trials. Nat Rev Cardiol (2014) 3.57
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation (2008) 3.30
Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat Med (2014) 3.23
The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov (2003) 3.19
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol (2007) 3.05
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell (2013) 2.32
Scaffold-free vascular tissue engineering using bioprinting. Biomaterials (2009) 2.32
Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci U S A (2009) 2.25
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev (2013) 2.24
Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A (2009) 2.14
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials (2013) 1.97
Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov (2015) 1.95
3D printed bionic ears. Nano Lett (2013) 1.80
Omnidirectional printing of 3D microvascular networks. Adv Mater (2011) 1.76
The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials (2005) 1.75
A review on stereolithography and its applications in biomedical engineering. Biomaterials (2010) 1.71
Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med (2013) 1.69
Challenges in cardiac tissue engineering. Tissue Eng Part B Rev (2010) 1.66
Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today (2012) 1.63
Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat Commun (2014) 1.60
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater (2013) 1.54
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci U S A (2016) 1.53
Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans Biomed Eng (2013) 1.46
Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc (2009) 1.45
iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol (2010) 1.42
3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J Biomed Mater Res A (2012) 1.41
Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication (2012) 1.39
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease. Sci Transl Med (2017) 1.39
Materials science. Printing cells. Science (2007) 1.38
Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol (2013) 1.38
Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP. PLoS One (2017) 1.37
Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One (2011) 1.34
Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip (2014) 1.34
Geometrically controlled endothelial tubulogenesis in micropatterned gels. Tissue Eng Part A (2010) 1.33
Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. Biomaterials (2012) 1.33
Three-dimensional bioprinting of thick vascularized tissues. Proc Natl Acad Sci U S A (2016) 1.26
Effects of dispensing pressure and nozzle diameter on cell survival from solid freeform fabrication-based direct cell writing. Tissue Eng Part A (2008) 1.25
Laser-guided direct writing for three-dimensional tissue engineering. Biotechnol Bioeng (2005) 1.21
Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol (2014) 1.20
Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci U S A (2013) 1.19
Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J (2012) 1.16
Engineering Stem Cell Organoids. Cell Stem Cell (2016) 1.15
Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Eur Heart J (2012) 1.10
Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods (2011) 1.10
Carbon nanotubes promote growth and spontaneous electrical activity in cultured cardiac myocytes. Nano Lett (2012) 1.09
Toward engineering functional organ modules by additive manufacturing. Biofabrication (2012) 1.08
3D printing of composite tissue with complex shape applied to ear regeneration. Biofabrication (2014) 1.06
Assembly of functionally integrated human forebrain spheroids. Nature (2017) 1.05
Direct 3D Printing of Shear-Thinning Hydrogels into Self-Healing Hydrogels. Adv Mater (2015) 1.03
Laser-based direct-write techniques for cell printing. Biofabrication (2010) 1.02
Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis. Nat Mater (2016) 1.01
Generation of three-dimensional hepatocyte/gelatin structures with rapid prototyping system. Tissue Eng (2006) 1.01
2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression. PLoS One (2012) 0.98
Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat Mater (2016) 0.97
3D bioprinting for engineering complex tissues. Biotechnol Adv (2015) 0.97
An additive manufacturing-based PCL-alginate-chondrocyte bioprinted scaffold for cartilage tissue engineering. J Tissue Eng Regen Med (2013) 0.95
Alignment of skeletal muscle myoblasts and myotubes using linear micropatterned surfaces ground with abrasives. Biotechnol Bioeng (2009) 0.94
Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials (2014) 0.93
Coaxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials (2015) 0.92
Biomimetic 3D tissue printing for soft tissue regeneration. Biomaterials (2015) 0.92
Carbon nanotubes instruct physiological growth and functionally mature syncytia: nongenetic engineering of cardiac myocytes. ACS Nano (2013) 0.92
Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. Circulation (2016) 0.90
Fabrication of scalable and structured tissue engineering scaffolds using water dissolvable sacrificial 3D printed moulds. Mater Sci Eng C Mater Biol Appl (2015) 0.87
Synthetic 3D multicellular systems for drug development. Curr Opin Biotechnol (2012) 0.87
Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat Commun (2016) 0.86
Three-dimensional printing of high-content graphene scaffolds for electronic and biomedical applications. ACS Nano (2015) 0.85
Bioprintable, cell-laden silk fibroin-gelatin hydrogel supporting multilineage differentiation of stem cells for fabrication of three-dimensional tissue constructs. Acta Biomater (2014) 0.85
Layer-by-layer assembly of 3D tissue constructs with functionalized graphene. Adv Funct Mater (2014) 0.84
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev (2015) 0.83
Biomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair. Stem Cell Res Ther (2013) 0.83
Three-dimensional bioprinting of multilayered constructs containing human mesenchymal stromal cells for osteochondral tissue regeneration in the rabbit knee joint. Biofabrication (2016) 0.83
Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials (2016) 0.82
Controlling the orientation and synaptic differentiation of myotubes with micropatterned substrates. Biophys J (2009) 0.82
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells. EMBO Mol Med (2016) 0.81
One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology. Lab Chip (2016) 0.81
Induction of initial steps of angiogenic differentiation and maturation of endothelial cells by pericytes in vitro and the role of collagen IV. Histochem Cell Biol (2016) 0.81